Thus, IL6-KO mice develop mature-onset obesity [18], whereas transgenic mice overexpressing IL-6 in astrocytes (GFAP-IL6 mice) are resistant to HFD-induced obesity [19]. Here, GFAP is linked to obesity disorder.